meistermell
Posted - 12 hours ago
$ESPR $XERS
ronday19200
Posted - 13 hours ago
$XERS
SparkyReturns
Posted - 13 hours ago
$XERS Santa is loading up the sleigh and Mrs. Claus is in the kitchen on her brokerage account smashing the buy button. Cheers! Happy Holidays!
BarbarianTrades
Posted - 14 hours ago
$XERS big money on the tape. Merry Christmas all!
Ithaca2018
Posted - 23 hours ago
$XERS We shopped until we dropped! But nice to see us up after hours! It's a happy holiday season here in Chicago, Go XERS!
BuyThisOne
Posted - 1 day ago
$XERS Does anyone have knowledge of how the partnership option agreements work when a collab deal is struck? Are the financial terms of the agreement set at that point or is it negotiated when the company decides to move forward with the option? Do these options usually have an expiration date attached? Just thinking that if they don't have an answer from Regeneron by the March earnings call do they add the potential for an upfront payment in their 2025 earnings guidance or leave it out completely? These things could be pretty set in stone or could always be up in the air on the details. Any insight would be appreciated on this.
SparkyReturns
Posted - 1 day ago
$XERS Hmmm....
meistermell
Posted - 1 day ago
$ESPR $XERS
hashemtrade
Posted - 1 day ago
$XERS You're going to say the same about 5$ once it passes 4$ clown.
Counselor53
Posted - 1 day ago
$XERS still in an ascending channel!
Counselor53
Posted - 1 day ago
$XERS I believe in March XERS will be ready to report CF+ information, especially with the Recorlev growth. The CEO payout should be out of the way as well, opening the door to report CF+news. Runs with Dogs is right- many new investors this Spring once we see that- and that it will be consistent from this point on. I think we see double digits in 2025.
RunsWithDogs
Posted - 1 day ago
$XERS Cheeto, 3% is plummeting? Under average daily volume is Big Volume? Really? Brodman, When it does pass $4, $8, $12 are you switching sentiment, or just remaining bitter? Alon_R, If you have been a biotech investor for as long as I have, you know that XP-8121 reaching Phase III trials won't even create a blip on the chart when compared to going Cash Flow Positive. What this company needs is positive earnings, analyst visibility and volume! All the other catalysts are gravy...
cheetohottaki
Posted - 1 day ago
$XERS wow big volume and plummeting, thanks XERS, merry Xmas to you as you always seem to disappoint us leadership team, so congrats on that this year, we can always count on yall to put a damper on things when everyone is riding high and excited about your future, well done as always!
Brodman
Posted - 1 day ago
$XERS Same old XERS can't hold any increases....hasn't seen $4 in YEARS and it won't be happening anytime soon. Will see $2s before it ever sees $4s.
Alon_R
Posted - 1 day ago
$XERS Two major catalysts soon ("Here&Now")
A)Very likely XP-8121 advancement to PH III announcement very soon. Even though nothing is a given, it based/rely on superb phase II clinical trial data, so it just makes sense. Reminder: Xeris mgmt(quite conservative mgmt), said that XP-8121 once approved, is very possible Blockbuster drug for Xeris. And if to be more accurate... For 20% upto 40% of Levo clientele(between $800M to $1.6B), XP-8121 SQ option will be very important once issued, maybe even crucial, in a matter to address a significant unmet need in hypothyroidism mgmt.
So how much shifting of XP-8121 to phase III will be implemented in sp upside? I can't tell. But it's of course the drug that alongside Recorlev and Gvoke and some Xeriject deals, may take Xeris to 3 digits worth. B)II catalyst - Huge Recorlev growth (I think it's in a midst of a significant leap, that will lead Xeris to profitability very soon) Reminder: only ~15% of traded Bio comp. are profitabile.
pascallambrecht
Posted - 1 day ago
$XERS happy 2025 soon we need to go to 4/5 level
NewEra8
Posted - 1 day ago
$XERS
stockpsyche
Posted - 2 days ago
$XERS beautiful 1 year chart. Congrats all. Company looks in great shape with more to come. Never got in, but always root for you. Some good folx on this board @Ithaca2018. 🥳
Maissessap
Posted - 2 days ago
$XERS All in all this is a very slow growing company. What is the reason to delay for so long the Levo P3???
BuyThisOne
Posted - 3 days ago
$XERS What's on deck you ask? 1.) 3 approved products, 2 of which are growing. 2.) Recorlev(for cushings and hypercortisolemia) grew $4.3 million Q2 to Q3 and may continue at this pace to $300 million plus. 3.) CF+ most likely in 2025 and maintained. 4.) 20%+ growth expected for at least next couple of years. 5.) Waiting on Regeneron to analyze stability studies for Xeriject on a couple molecules and potentially sign a platform partnership deal in 1st quarter. 6.) Gvoke should continue stealing market share from Baqsimi and grow to $200 million over the next 10 years. 7.) Once a week Levothyroxine shot Phase 3 clinical trial update in first half of 2025. 8.) Clinical trials for Amgen Tepezza Xeriject or Beta Bionics Xerisol Glucagon could get updates at any time. 9.) Another Xeriject/Xerisol deal could always be announced at any time as discussions are always taking place. SubQ market is expected to be $34 billion plus. Future is looking great. My price target is $4 for 2024 and $8 for 2025
BuyThisOne
Posted - 3 days ago
$XERS Only 10 weeks to go until earnings call for 2024. If they provide guidance for CF+, report record revenues, continued Recorlev growth and we land the Regeneron deal, where do you think that will put us? We would have to see at least $5 or $6 right? I would say at least $8 but I have been here too long to expect something reasonable.
Ithaca2018
Posted - 3 days ago
$XERS Tomorrow our MVP NewEra8, rocks the field in Baltimore against the Steelers. A flock of beautiful Ravens flying in synchrony shall take the win!
meistermell
Posted - 4 days ago
$ESPR $XERS
Bearly_Bullish_Trader
Posted - 4 days ago
$XERS time to break $4.
Aptos2024
Posted - 4 days ago
$XERS lol a 35 share trade A/H moves the needle 15 cents! Where is Sonnier!!!!
simonig1
Posted - 4 days ago
$XERS @LurkerBoy The moon is just a pitstop. To the Stars! ;-0)
LurkerBoy
Posted - 4 days ago
$XERS To the moon!
simonig1
Posted - 4 days ago
$XERS Here is today's chart about 20 minutes before the close. Bothe the short-term and long-term uptrends are intact!! Enjoy!!
Nizmeister
Posted - 4 days ago
$XERS from $amph q3 earnings report on glucagon sales: Glucagon sales decreased by 9% to $26.8 million due to increased competition in the market, reflecting a decline in unit shipments. we comin for dat ass.
dave2ta
Posted - 4 days ago
$XERS I just checked my Spotify Artist Page and saw Over 24 Thousand Streams for my Dave Evans Solo Vol. 1 Album.. they are from all over the world. It's very exciting to put your music out there and see it accepted and listened to... Here's a link to it on Spotify, please enjoy listening... 👍
https://open.spotify.com/album/2QOuw62TQkAa8ElNDeFkTa?si=Z2dELKPJSEyDQIaeUBT5lQ